Bristol Myers Squibb

Bristol-Myers Squibb is a pharmaceutical business based in New York City. Edward Robinson Squibb, who was well-known at the time for his zealous advocacy for greater quality control standards in medicine, formed Myers Squibb in the mid-1800s. The corporation is now one among the world's largest pharmaceutical companies, with a market capitalization of $98.2 billion last year.

Bristol Myers Squibb is a multinational biopharmaceutical firm dedicated to improving the lives of people throughout the globe by developing genuinely revolutionary medications that help them overcome serious diseases. Bristol Myers Squibb manufactures prescription medications and biologics for cancer, HIV/AIDS, cardiovascular disease, diabetes, hepatitis, rheumatoid arthritis, and mental disorders, among other therapeutic areas.

Bristol Myers Squibb made $26.15 billion in sales in 2019. Bristol-Myers Squibb announced a $10.8 billion first-quarter 2020 profit. Revenues of $10.1 billion in the second quarter of 2020 represented a 61 percent gain on a reported basis, or a 63 percent increase when adjusted for foreign exchange. The impact of the Celgene purchase, which was finalized on November 20, 2019, was the primary driver of the rise. Bristol Myers Squibb made $10.5 billion in revenue in the third quarter of 2020.

Founded: 1960
Headquarters: Lawrence Township, NJ
Market Cap: 131.91B USD
Website: https://www.bms.com/